Aviva PLC Moderna, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Aviva PLC holds 249,476 shares of MRNA stock, worth $10 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

249,476

Previous 166,897 49.48%

Holding current value

$10 Million

Previous $19.8 Million 15.88%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $5.26 Million - $10.3 Million	82,579 Added 49.48%	249,476 $16.7 Million
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $5.54 Million - $9.12 Million	54,766 Added 48.84%	166,897 $19.8 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $2.98 Million - $4.03 Million	-34,947 Reduced 23.76%	112,131 $11.9 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $2.45 Million - $3.69 Million	35,310 Added 31.59%	147,078 $14.6 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $3.56 Million - $4.67 Million	36,881 Added 49.25%	111,768 $11.5 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $16.5 Million - $22.3 Million	-139,116 Reduced 65.01%	74,887 $9.1 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $6.59 Million - $9.57 Million	48,554 Added 29.35%	214,003 $32.9 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $429,719 - $762,445	3,630 Added 2.24%	165,449 $29.7 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2.6 Million - $4.28 Million	-22,042 Reduced 11.99%	161,819 $19.1 Million
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $8.69 Million - $13.1 Million	74,156 Added 67.6%	183,861 $26.3 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $6.97 Million - $13 Million	55,118 Added 100.97%	109,705 $18.9 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $960,186 - $1.57 Million	-4,252 Reduced 7.23%	54,587 $13.9 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $11.1 Million - $24.3 Million	-50,133 Reduced 46.01%	58,839 $22.6 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $1.81 Million - $3.27 Million	13,910 Added 14.63%	108,972 $25.6 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $121,189 - $206,437	1,110 Added 1.18%	95,062 $12.4 Million
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $242,514 - $626,613	3,689 Added 4.09%	93,952 $9.82 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $4.9 Million - $8.56 Million	90,263 New	90,263 $6.39 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account